Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Similares em SciELO
Compartilhar
Horizonte sanitario
versão On-line ISSN 2007-7459versão impressa ISSN 1665-3262
Resumo
GARCIA-MILIAN, Ana Julia; GALVEZ-ALVAREZ, Yordanka; GONZALEZ-DEL SOL, Mayné e LEON-CABRERA, Pablo. Pattern of consumption of antineoplastic used for the treatment of cancer in Havana 2011-2015. Horiz. sanitario [online]. 2018, vol.17, n.1, pp.39-50. ISSN 2007-7459. https://doi.org/10.19136/hs.a17n1.1989.
Objective:
To characterize the consumption pattern of the antineoplastic drugs used for the treatment of patients with neoplastic in the province of La Habana during the period 2011-2015.
Materials and methods:
Descriptive study of the use of consumer drugs with elements of practical consequences expressed in units sold. The data were obtained from the database of drugstore, according to National Formulary of Medications, present each year in the Basic Chart, during the period 2011-2015, belonging to the Basic Chart of Medicines of the province. The consumption data in physical units of the antineoplastic ones were obtained from the sales by products of the Business Unit of Base Wholesale of Medicine Havana. The prices were obtained from the oficial price list: PRECIOS1, from the Ministry of Finance and Prices. Ideal consumption was considered as planned according to the demand of health institutions and real to the number of units sold to these institutions.
Results:
Consumption in general was upward in each year of study from (488578) to (753587). The highest consumption was concentrated on nitrogen mustards (116709), folic acid analogues (113333), platines (70336), podophyllotoxin derivatives (61551) and monoclonal antibodies (38294). The cost of drug consumption was $ 51,403,612.75.
Conclusions:
The pattern of consumption according to units sold was characterized by an increase of the same by years of study in the different subgroups independently of the compliance or not of the requests demanded by the health units. The economic value of antineoplastic consumption increased. Monoclonal antibodies were the highest cost group identified in the study.
Palavras-chave : Cost; Consumption; Medication; Antineoplastics.